Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress

被引:99
作者
Tsuda, M
Iwai, M
Li, JM
Li, HS
Min, LJ
Ide, A
Okumura, M
Suzuki, J
Mogi, M
Suzuki, H
Horiuchi, M [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Mol & Cellular Biol, Div Med Biochem & Cardiovasc Biol, Shigenobu, Ehime 7910295, Japan
[2] Saitama Med Sch, Dept Nephrol, Moroyama, Saitama 35004, Japan
关键词
atherosclerosis; estrogen; oxidative stress; receptors; angiotensin II;
D O I
10.1161/01.HYP.0000157409.88971.fc
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The present study explored the possibility that estrogen enhances the inhibitory effect of an angiotensin II type-1 (AT(1)) receptor blocker (ARB), olmesartan, on atherosclerosis, focusing on oxidative stress using apolipoprotein E knockout mice (ApoEKO). After 6 weeks on a high-cholesterol diet, marked atherosclerotic lesion formation with an increase in oxidative stress, such as superoxide production, NAD(P)H oxidase activity and expression of p47(phox) mRNA and rac-1 mRNA, were observed in the proximal aorta in both male and female ApoEKO mice, whereas these changes were less marked in female mice. Ovariectomy enhanced these parameters, the changes of which were reversed by 17 beta-estradiol (80 mu g/kg per day) replacement. Treatment with olmesartan (3 mg/kg per day) significantly inhibited oxidative stress and atherosclerosis, whereas its inhibitory effects were more marked in female than in male or ovariectomized mice. Smaller doses of olmesartan (0.5 mg/kg per day) or 17 beta-estradiol (20 mu g/kg per day) did not influence atherosclerosis and oxidative stress in ovariectomized mice, whereas co-administration of olmesartan and 17 beta-estradiol at these doses attenuated these parameters. An angiotensin-converting enzyme (ACE) inhibitor, temocapril, also inhibited atherosclerotic changes similarly to olmesartan. Moreover, angiotensin II-mediated activation of NAD( P) H oxidase in cultured vascular smooth muscle cells was attenuated by 17 beta-estradiol. These results indicate that estrogen and an ARB synergistically attenuate atherosclerosis at least partly via inhibition of oxidative stress.
引用
收藏
页码:545 / 551
页数:7
相关论文
共 35 条
  • [21] Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice
    Ozaki, M
    Kawashima, S
    Yamashita, T
    Hirase, T
    Namiki, M
    Inoue, N
    Hirata, K
    Yasui, H
    Sakurai, H
    Yoshida, Y
    Masada, M
    Yokoyama, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (03) : 331 - 340
  • [22] Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro - Implications for atherosclerotic plaque stability
    Rajagopalan, S
    Meng, XP
    Ramasamy, S
    Harrison, DG
    Galis, ZS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) : 2572 - 2579
  • [23] Hormones, genetic factors, and gender differences in cardiovascular disease
    Rossouw, JE
    [J]. CARDIOVASCULAR RESEARCH, 2002, 53 (03) : 550 - 557
  • [24] Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity
    Sanada, M
    Higashi, Y
    Nakagawa, K
    Sasaki, S
    Kodama, I
    Sakashita, T
    Tsuda, M
    Ohama, K
    [J]. ATHEROSCLEROSIS, 2001, 158 (02) : 391 - 397
  • [25] Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck
    Schmitz, U
    Thömmes, K
    Beier, I
    Wagner, W
    Sachinidis, A
    Düsing, R
    Vetter, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) : 22003 - 22010
  • [26] Angiotensin II stimulation of NAD(P)H oxidase activity - Upstream mediators
    Seshiah, PN
    Weber, DS
    Rocic, P
    Valppu, L
    Taniyama, Y
    Griendling, KK
    [J]. CIRCULATION RESEARCH, 2002, 91 (05) : 406 - 413
  • [27] CHARACTERIZATION OF THE VASCULAR THROMBOXANE-A2 PROSTAGLANDIN ENDOPEROXIDE RECEPTOR IN RABBIT AORTA - REGULATION BY DEXAMETHASONE
    SESSA, WC
    HALUSHKA, PV
    OKWU, A
    NASJLETTI, A
    [J]. CIRCULATION RESEARCH, 1990, 67 (06) : 1562 - 1569
  • [28] POSTMENOPAUSAL ESTROGEN THERAPY AND CARDIOVASCULAR-DISEASE - 10-YEAR FOLLOW-UP FROM THE NURSES HEALTH STUDY
    STAMPFER, MJ
    COLDITZ, GA
    WILLETT, WC
    MANSON, JE
    ROSNER, B
    SPEIZER, FE
    HENNEKENS, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (11) : 756 - 762
  • [29] Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II
    Takeda-Matsubara, Y
    Nakagami, H
    Iwai, M
    Cui, TX
    Shiuchi, T
    Akishita, M
    Nahmias, C
    Ito, M
    Horiuchi, M
    [J]. HYPERTENSION, 2002, 39 (01) : 41 - 45
  • [30] Reactive oxygen species in the vasculature - Molecular and cellular mechanisms
    Taniyama, Y
    Griendling, KK
    [J]. HYPERTENSION, 2003, 42 (06) : 1075 - 1081